YOLANDA LAWSON: Open Payments
NPI 1952071912 · JACKSONVILLE, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,949 in 101 payments from 25 companies in 2025. Trend: 2023 $2,468 · 2024 $2,405 · 2025 $1,949
Food & beverage: $1,949
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 11 | $284 |
| AstraZeneca Pharmaceuticals LP | 12 | $218 |
| ABBVIE INC. | 10 | $170 |
| Corcept Therapeutics | 8 | $166 |
| Bayer Healthcare Pharmaceuticals Inc. | 8 | $157 |
| Lilly USA, LLC | 9 | $148 |
| Novo Nordisk Inc | 7 | $126 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 6 | $112 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 6 | $84 |
| Abbott Laboratories | 4 | $79 |
Products named: JYNARQUE, Korlym, Kerendia, JARDIANCE, AIRSUPRA, CAPLYTA, MOUNJARO, UBRELVY.
Industry payments across FL — which companies pay providers there.
